Replies to post #264176 on Anavex Life Sciences Corp (AVXL)

[tootalljones]

the poster did not say he said "good."

[he felt confident that the results of it would be "very good"]

It is a double blind study. https://clinicaltrials.gov/ct2/show/NCT03774459?term=NCT03774459&draw=2&rank=1

Theoretically speaking of course, and just for funzies,
but what might be the basis for him to use the term "very good,"...(presuming he actually used this term, and I know he works for the company)
I am parsing this, but still.....what would be the sources that he might bring to bear,
on this bank and shoal of time,
to use the term very good?

call me naive or anything you want (but not late for dinner), but my spidey senses are tingling just a tiny bit........nothing is ever routine with a little biotech or little company, or rather much is ordinary but much is not.

[anders2211]

How is any of that even close to relevant and investable?

the information is useful for two reasons.

1. we now know PDD data is still a mystery to them, that's useful to know
This means that Missling has avoided talking about PDD at the CC so they can't find a signal conclusion etc is nonsense.

2. They are indeed aiming for PA if the data would support such. It has been claimed that they were going to go after PDD P3 no matter what, Use full to know to